Abstract: SA-OR070
Macrophage Mitophagy Deficiency Promotes Experimental and Human Kidney Fibrosis
Session Information
- Mechanisms of Kidney and Cardiovascular Damage in CKD
November 09, 2019 | Location: 206, Walter E. Washington Convention Center
Abstract Time: 04:54 PM - 05:06 PM
Category: CKD (Non-Dialysis)
- 2103 CKD (Non-Dialysis): Mechanisms
Authors
- Bhatia, Divya, Weill Cornell Medicine, New York, New York, United States
- Chung, Kuei-Pin, Weill Cornell Medicine, New York, United States
- Nakahira, Kiichi, Weill Cornell Medicine, New York, New York, United States
- Patino, Edwin, Weill Cornell Medicine, New York, New York, United States
- Rice, Michelle C., Weill Cornell Medicine, New York, New York, United States
- Torres, Lisa K., Weill Cornell Medicine, New York, New York, United States
- Muthukumar, Thangamani, Weill Cornell Medicine, New York, New York, United States
- Choi, Augustine MK, Weill Cornell Medicine, New York, New York, United States
- Akchurin, Oleh M., Weill Cornell Medicine, New York, New York, United States
- Choi, Mary E., Weill Cornell Medicine, New York, New York, United States
Background
Mitochondrial quality control by mitophagy is critical for normal kidney function. We examined the role of PINK1, Mitofusin 2 (MFN2) and Parkin-mediated mitophagy in macrophage-induced kidney fibrosis, using experimental models of adenine diet (AD) or unilateral ureteral obstruction (UUO) and in human kidney fibrosis.
Methods
Kidney fibrosis in Pink1-/- or Prkn-/- mice was induced by AD or UUO. Role of MFN2 was studied using LysM-Cre+/-Mfn2fl/fl mice. Kidney tissues and primary macrophages were analyzed by flow cytometry, confocal and electron microscopy, qPCR, western blot, ELISA, and MitoStress test. PBMCs, plasma and kidney biopsies from patients with severe-CKD (GFR<30 ml/min/1.73m2,n=15) or biopsy-proven interstitial fibrosis & tubular atrophy (IFTA,n=6) were compared to patients with mild/moderate-CKD (GFR>30,n=8) or controls (no CKD,n=9).
Results
Expression of PINK1, MFN2, and Parkin was decreased in kidneys and renal macrophages after AD or UUO, as well as in TGF-β1-treated bone-marrow-derived macrophages (BMDMs), human renal macrophages, and THP-1-cells. Kidneys from Pink1-/- and Prkn-/- mice showed higher fibronectin, collagen-I, TGF-β1, galectin-3, and arginase-I after AD or UUO vs corresponding wild-type mice. Renal macrophages from AD-fed Pink1-/-mice had a higher number of abnormal mitochondria. Ly6ClowCD11b+, F4.80+CD206+ cells and CCL2 levels were increased in blood and kidneys from Pink1-/- and Prkn-/-mice after AD or UUO. Mitochondria from TGF-β1-treated Pink1-/- BMDMs showed lower respiration, higher mitochondrial ROS (mROS), and reduced colocalization with LC3. Mitophagy inhibition by Pink1-siRNA or Mdivi-1 resulted in decreased phosphorylation of downstream MFN2 and increased fibrotic response by human macrophages. LysM-Cre+/-Mfn2fl/fl macrophage mitochondria displayed lower recruitment of Parkin and mitophagy. Plasma, PBMCs, and kidney biopsies from patients with severe-CKD and IFTA showed higher CCL2 and mROS, and lower PINK1, MFN2 and PRKN expression.
Conclusion
Our study is the first to demonstrate that deficiency of PINK1/MFN2/PRKN-mediated mitophagy promotes macrophage-induced oxidative stress and fibrotic response, and is associated with human kidney fibrosis. Therapeutically targeting macrophage mitophagy pathway may protect against kidney fibrosis.
Funding
- NIDDK Support